Key Insights

Highlights

Treatment Research

1 treatments under study, led by Ct Perfusion

Related Conditions

Often studied with 6 related conditions

Clinical Risk Assessment

Based on trial outcomes

High Risk

Score: 100/100

Termination Rate

100.0%

1 terminated out of 1 trials

Success Rate

0.0%

-86.6% vs benchmark

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 0 completed with results

Key Signals

0

Data Visualizations

Phase Distribution

Trial Status

Terminated1

Clinical Trials (1)

Showing 1 of 1 trials
NCT01163526Terminated

Perfusion CT as a Predictor of Treatment Response in Patients With Hepatic Malignancies

Showing all 1 trials

Research Network

Common Treatments

  • Ct Perfusion1

Active Sponsors

  • GE Healthcare1
  • Siemens Corporation, Corporate Technology1
  • Stanford University1

Top Investigators

Related Conditions

  • Neuroendocrine Tumors1
  • Brain Nervous System Cancers1
  • Colon Cancer1
  • Hepatobiliary Cancers1
  • Liver1

Activity Timeline